Idiosyncratic drug reactions: the reactive metabolite syndromes
- PMID: 11075787
- DOI: 10.1016/S0140-6736(00)03137-8
Idiosyncratic drug reactions: the reactive metabolite syndromes
Abstract
Idiosyncratic drug reactions are unpredictable reactions that can result in significant morbidity and mortality. Severe reactions are often characterised by fever and internal organ involvement. Despite progress in the identification of reactive metabolites believed to be the cause of idiosyncratic reactions, the basic mechanisms remain elusive. Furthermore, because of the lack of consensus regarding definition of these syndromes, reporting, and therefore epidemiological data, are often unreliable. Research is needed to explore further the pathophysiology of these reactions, so that better diagnostic tests and treatment methods can be developed.
Comment in
-
Adverse drug reactions.Lancet. 2001 Feb 17;357(9255):561. doi: 10.1016/S0140-6736(05)71713-X. Lancet. 2001. PMID: 11229702 No abstract available.
Similar articles
-
Adverse drug reactions.Compr Ther. 1980 Apr;6(4):22-30. Compr Ther. 1980. PMID: 7389291 No abstract available.
-
Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions.Crit Rev Toxicol. 1990;20(4):213-35. doi: 10.3109/10408449009089863. Crit Rev Toxicol. 1990. PMID: 2178625 Review.
-
Reactive metabolites and adverse drug reactions: clinical considerations.Clin Rev Allergy Immunol. 2003 Jun;24(3):229-38. doi: 10.1385/CRIAI:24:3:229. Clin Rev Allergy Immunol. 2003. PMID: 12721394 Review.
-
The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions.Drug Metab Rev. 1992;24(3):299-366. doi: 10.3109/03602539208996297. Drug Metab Rev. 1992. PMID: 1628536 Review.
-
The role of reactive drug metabolites in immune-mediated adverse drug reactions.Ann Pharmacother. 1997 Nov;31(11):1378-87. doi: 10.1177/106002809703101116. Ann Pharmacother. 1997. PMID: 9391694 Review.
Cited by
-
The role of in vitro testing in pharmacovigilance for ß-lactam-induced serum sickness-like reaction: A pilot study.Front Pharmacol. 2022 Aug 30;13:945545. doi: 10.3389/fphar.2022.945545. eCollection 2022. Front Pharmacol. 2022. PMID: 36110527 Free PMC article.
-
Drug-induced liver injury.Drug Saf. 2007;30(4):277-94. doi: 10.2165/00002018-200730040-00001. Drug Saf. 2007. PMID: 17408305 Review.
-
Characterization of reactive intermediates formation in dacomitinib metabolism and bioactivation pathways elucidation by LC-MS/MS: in vitro phase I metabolic investigation.RSC Adv. 2018 Nov 19;8(68):38733-38744. doi: 10.1039/c8ra06709k. eCollection 2018 Nov 16. RSC Adv. 2018. PMID: 35558335 Free PMC article.
-
Chronic administration of oral trimethoprim-sulfamethoxazole for acne vulgaris.J Clin Aesthet Dermatol. 2011 Aug;4(8):58-66. J Clin Aesthet Dermatol. 2011. PMID: 21909458 Free PMC article. No abstract available.
-
Identification of Iminium Intermediates Generation in the Metabolism of Tepotinib Using LC-MS/MS: In Silico and Practical Approaches to Bioactivation Pathway Elucidation.Molecules. 2020 Oct 28;25(21):5004. doi: 10.3390/molecules25215004. Molecules. 2020. PMID: 33126762 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical